DURECT Corporation Posted gains of 21.25% in the Last Trade

DURECT Corporation's (DRRX) witnessed a gain of 4.12% in recent trading period with closing price of $ 1.01. The RSI oscillates between zero and 100.

Receive Durect Corporation News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Durect Corporation with MarketBeat.com's FREE daily email newsletter.

Small cap biotech Durect Corporation has signed a $20 million upfront deal, with biobucks down the line, with Novartis for the biotech's troubled late-stage asset that has seen a series of setbacks and name changes in recent years. As volatility place a very vital role in identifying the risk involved in the particular case. It has been assigned a low target price of $47 and a high target price of $65. They may also be used to assist the trader figure out proper support and resistance levels for the stock. A beta approximates the overall volatility of a security's returns against the returns of a relevant benchmark (usually the S&P 500 is used). Recall, as a general guideline, when the price is above a moving average the trend is considered up.

Let's take a look at some historical average volume information on shares of Durect Corporation (DRRX). The oil and gas exploration and production company posted revenue of $285.1 million in the period, also surpassing Street forecasts. The average P/E ratio of 60.13 times earnings. Sell-side analyst recommendations point to a short term price target of $58.6 on the company shares.

DURECT is a biopharmaceutical company actively developing new therapeutics based on its Epigenetic Regulator Program and proprietary drug delivery platforms. The company's market capitalization is $167.67 billion with the total outstanding shares of 5.01 billion. "Ultimately, through all this investigation into the company's performance the analyst decides whether their stock is a "buy", sell" or hold". Durect Corporation has a 52-week low of 0.74 and a 52-week high of 2.00. The stock's price is floating in a range of $0.95 and $1.04 whereas, it's 52-week High Price is $2.00 with respect to its 52-week Low Price of $0.74.

Stock is now moving with a negative distance from the 200 day simple moving average of approximately -24.18%, and has a poor year to date (YTD) performance of -27.61% which means the stock is constantly subtracting to its value from the previous fiscal year end price.

DURECT Corporation (DRRX) has an Average Brokerage Recommendation (ABR) of 2, according to data compiled by Zacks Investment Research. If the average volume is low then the liquidity is low which means it is hard to buy or sell the stock as there are fewer buyers or sellers of the stock.

A trend analysis is a method of analysis that allows traders to predict what will happen with a stock in the future.

DURECT Corporation shares increased 26.58 percent over the past week and rose 2.04 percent over the previous month. The stock plunged -0.99 percent over the past quarter, while declined -13.04 percent over the past six months.